KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cme (CME) Other Accumulated Expenses (2016 - 2025)

Cme (CME) has disclosed Other Accumulated Expenses for 17 consecutive years, with $568.8 million as the latest value for Q4 2025.

  • On a quarterly basis, Other Accumulated Expenses fell 78.03% to $568.8 million in Q4 2025 year-over-year; TTM through Dec 2025 was $568.8 million, a 78.03% decrease, with the full-year FY2025 number at $568.8 million, down 78.03% from a year prior.
  • Other Accumulated Expenses was $568.8 million for Q4 2025 at Cme, up from $471.1 million in the prior quarter.
  • In the past five years, Other Accumulated Expenses ranged from a high of $3.1 billion in Q4 2023 to a low of $379.1 million in Q2 2021.
  • A 5-year average of $927.0 million and a median of $581.0 million in 2023 define the central range for Other Accumulated Expenses.
  • Peak YoY movement for Other Accumulated Expenses: skyrocketed 39.4% in 2022, then crashed 78.03% in 2025.
  • Cme's Other Accumulated Expenses stood at $1.7 billion in 2021, then skyrocketed by 39.4% to $2.3 billion in 2022, then surged by 36.2% to $3.1 billion in 2023, then decreased by 17.39% to $2.6 billion in 2024, then plummeted by 78.03% to $568.8 million in 2025.
  • Per Business Quant, the three most recent readings for CME's Other Accumulated Expenses are $568.8 million (Q4 2025), $471.1 million (Q3 2025), and $544.5 million (Q2 2025).